206 related articles for article (PubMed ID: 25692902)
1. Medical management, costs, and consequences of Alzheimer's disease in Germany: an analysis of health claims data.
Brüggenjürgen B; Andersohn F; Ezzat N; Lacey L; Willich S
J Med Econ; 2015 Jun; 18(6):466-73. PubMed ID: 25692902
[TBL] [Abstract][Full Text] [Related]
2. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254
[TBL] [Abstract][Full Text] [Related]
3. The adoption of pharmaceutical innovation and its impact on the treatment costs for Alzheimer's disease in Taiwan.
Lo TF; Hsieh CR
J Ment Health Policy Econ; 2014 Sep; 17(3):107-17. PubMed ID: 25543114
[TBL] [Abstract][Full Text] [Related]
4. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
[TBL] [Abstract][Full Text] [Related]
5. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
Fillit H; Hill JW; Futterman R
Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
[TBL] [Abstract][Full Text] [Related]
6. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
[TBL] [Abstract][Full Text] [Related]
7. Medical Care and Long-Term Care Expenditures Attributable to Alzheimer's Disease Onset: Results from the LIFE Study.
Fukuda H; Ono R; Maeda M; Murata F
J Alzheimers Dis; 2021; 84(2):807-817. PubMed ID: 34602465
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.
Sicras A; Rejas J; Arco S; Flores E; Ortega G; Esparcia A; Suárez A; Gordillo MJ
Dement Geriatr Cogn Disord; 2005; 19(5-6):305-15. PubMed ID: 15785031
[TBL] [Abstract][Full Text] [Related]
10. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
Lu S; Hill J; Fillit H
Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
[TBL] [Abstract][Full Text] [Related]
11. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.
Taipale H; Purhonen M; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S
Scand J Public Health; 2016 Mar; 44(2):150-8. PubMed ID: 26553247
[TBL] [Abstract][Full Text] [Related]
12. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
[TBL] [Abstract][Full Text] [Related]
13. Burden of Alzheimer's disease and association with negative health outcomes.
Malone DC; McLaughlin TP; Wahl PM; Leibman C; Arrighi HM; Cziraky MJ; Mucha LM
Am J Manag Care; 2009 Aug; 15(8):481-8. PubMed ID: 19670951
[TBL] [Abstract][Full Text] [Related]
14. Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs.
Suehs BT; Shah SN; Davis CD; Alvir J; Faison WE; Patel NC; van Amerongen D; Bobula J
J Am Geriatr Soc; 2014 Mar; 62(3):435-41. PubMed ID: 24576203
[TBL] [Abstract][Full Text] [Related]
15. Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.
Gore M; Tai KS; Sadosky A; Leslie D; Stacey BR
J Med Econ; 2011; 14(4):497-507. PubMed ID: 21682606
[TBL] [Abstract][Full Text] [Related]
16. Cost effects of a specialized care center for people with Alzheimer's disease.
Bloom BS; Chhatre S; Jayadevappa R
Am J Alzheimers Dis Other Demen; 2004; 19(4):226-32. PubMed ID: 15359560
[TBL] [Abstract][Full Text] [Related]
17. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.
Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT; Doshi JA
J Med Econ; 2014 Feb; 17(2):148-58. PubMed ID: 24168640
[TBL] [Abstract][Full Text] [Related]
18. The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis.
Divino V; Dekoven M; Warner JH; Giuliano J; Anderson KE; Langbehn D; Lee WC
J Med Econ; 2013 Aug; 16(8):1043-50. PubMed ID: 23789925
[TBL] [Abstract][Full Text] [Related]
19. Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials.
Kahle-Wrobleski K; Fillit H; Kurlander J; Reed C; Belger M
Eur J Health Econ; 2015 Dec; 16(9):995-1004. PubMed ID: 25410743
[TBL] [Abstract][Full Text] [Related]
20. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
